OUTCOMES IN PATIENTS ALLOCATED TO NO-ASCT BASED ON DEPTH OF RESPONSE: INITIAL RESULTS OF A PHASE 2 TRIAL ASSESSING THE IMPACT OF MINIMAL RESIDUAL DISEASE (MRD) IN PATIENTS WITH DEFERRED ASCT (PADIMAC)Rickin Popat, Dunnya De‐Silva, Elizabeth H. Phillips et al.|St George's Online Research Archive (St George's University of London)|2017Cited by 0